Companies / India
Eisai Announces Results, Invests In India
May 2006 | FDI AlertJapan's Eisai, the country's fourth-largest drugmaker, has announced strong results for the 2005/06 financial year. Recurring profit rose 12.3% to JPY100bn (US$909.4mn) on the back of strong sales of new Alzheimer's drug Aricept. The company has forecast a 4% increase in recurring profit for this financial year, mainly due to government price cuts in the home
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
